| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1055-9965.EPI-10-0974 |
| P8608 | Fatcat ID | release_zkncwr65tndhnezzj42sxh6eqa |
| P932 | PMC publication ID | 3064558 |
| P698 | PubMed publication ID | 21364029 |
| P5875 | ResearchGate publication ID | 50249977 |
| P50 | author | Amanda Phipps-Green | Q59191864 |
| Mara Z Vitolins | Q61319157 | ||
| Thomas Rohan | Q87760016 | ||
| Lewis Kuller | Q88077314 | ||
| Rowan T Chlebowski | Q89795128 | ||
| Anne McTiernan | Q91493819 | ||
| Dorothy S Lane | Q91756399 | ||
| Marcia L. Stefanick | Q109542605 | ||
| Geoffrey Kabat | Q18924940 | ||
| Jean Wactawski-Wende | Q30001860 | ||
| P2093 | author name string | Lucile L Adams-Campbell | |
| Christopher I Li | |||
| Ross Prentice | |||
| P2860 | cites work | Recreational Physical Activity and Risk of Postmenopausal Breast Cancer Based on Hormone Receptor Status | Q61670381 |
| Upper abdominal obesity, insulin resistance and breast cancer risk | Q74202138 | ||
| Relation of BMI and physical activity to sex hormones in postmenopausal women | Q79216212 | ||
| Physical activity and postmenopausal breast cancer: effect modification by breast cancer subtypes and effective periods in life | Q82705460 | ||
| Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States) | Q83192020 | ||
| The epidemiology of triple-negative breast cancer, including race | Q24289471 | ||
| Risk factors for triple-negative breast cancer in women under the age of 45 years | Q24644075 | ||
| Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health | Q28288766 | ||
| Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). | Q32066754 | ||
| Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance | Q33941406 | ||
| Association of physical activity with hormone receptor status: the Shanghai Breast Cancer Study | Q34248104 | ||
| The Women's Health Initiative recruitment methods and results | Q34272010 | ||
| Compendium of physical activities: classification of energy costs of human physical activities | Q34348533 | ||
| Epidemiology of basal-like breast cancer | Q34639174 | ||
| Physical activity and breast cancer: a systematic review. | Q36666202 | ||
| Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women | Q36922387 | ||
| Mechanisms linking physical activity with cancer | Q37072358 | ||
| Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival | Q37249243 | ||
| Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. | Q37263790 | ||
| Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis | Q37780134 | ||
| Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group | Q39513392 | ||
| Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study | Q39605778 | ||
| Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. | Q39837918 | ||
| Anthropometry and breast cancer. Body size--a moving target | Q40676792 | ||
| Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies | Q41751734 | ||
| Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer | Q42450903 | ||
| Differences in risk factors for breast cancer molecular subtypes in a population-based study | Q42509874 | ||
| Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry | Q42510173 | ||
| Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women | Q44472863 | ||
| Risk factors for breast cancer according to estrogen and progesterone receptor status | Q44753983 | ||
| Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis | Q45149732 | ||
| Dual effects of weight and weight gain on breast cancer risk | Q47300501 | ||
| Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women | Q47336453 | ||
| Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study | Q47339963 | ||
| Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study | Q47635079 | ||
| Usual Physical Activity and Endogenous Sex Hormones in Postmenopausal Women: The European Prospective Investigation into Cancer-Norfolk Population Study | Q57202697 | ||
| Adulthood Lifetime Physical Activity and Breast Cancer | Q57272084 | ||
| P433 | issue | 3 | |
| P921 | main subject | estrogen | Q277954 |
| estrogen-receptor positive breast cancer | Q18553636 | ||
| P304 | page(s) | 454-463 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer | |
| P478 | volume | 20 |
| Q34458312 | A prospective study of physical activity and breast cancer incidence in African-American women |
| Q55329617 | Adipocytes induce distinct gene expression profiles in mammary tumor cells and enhance inflammatory signaling in invasive breast cancer cells. |
| Q38553013 | Adiposity and cancer risk: new mechanistic insights from epidemiology |
| Q36245367 | Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study |
| Q42457782 | Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women |
| Q37689714 | Association between mammographic density and basal-like and luminal A breast cancer subtypes |
| Q35873283 | Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy |
| Q27012792 | Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status |
| Q34698840 | Body mass index and risk of breast cancer: a nonlinear dose-response meta-analysis of prospective studies |
| Q41553938 | Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer |
| Q47555930 | Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis |
| Q47154385 | Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: a dose-response meta-analysis with 3,318,796 subjects from 31 cohort studies. |
| Q36494140 | Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses |
| Q37685510 | Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter? |
| Q28397311 | Breast cancer subtypes and previously established genetic risk factors: a bayesian approach |
| Q35918620 | Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer |
| Q35162833 | Can molecular subtyping replace axillary nodal status as prognostic marker in breast cancer? |
| Q38901717 | Central obesity and risks of pre- and postmenopausal breast cancer: a dose-response meta-analysis of prospective studies |
| Q37292409 | Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity. |
| Q33751806 | Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis |
| Q38758522 | Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer |
| Q36549960 | Differential impact of body mass index and its change on the risk of breast cancer by molecular subtype: A case-control study in Japanese women |
| Q43790330 | Differential patterns of recurrence and specific survival between luminal A and luminal B breast cancer according to recent changes in the 2013 St Gallen immunohistochemical classification. |
| Q51054794 | Differential survival and recurrence patterns of patients operated for breast cancer according to the new immunohistochemical classification: analytical survey from 1997 to 2012. |
| Q36226056 | Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study |
| Q50083416 | Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention. |
| Q36104999 | Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women's Health Initiative: A Longitudinal Study from the United States |
| Q36941405 | Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831. |
| Q36386871 | Epidemiology of triple negative breast cancers |
| Q92533785 | Examining the relationship between sport and health among USA women: An analysis of the Behavioral Risk Factor Surveillance System |
| Q37058003 | Impact of body mass index on prognostically relevant breast cancer tumor characteristics |
| Q36894869 | Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women |
| Q35091234 | Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer |
| Q37679492 | Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk |
| Q33573884 | Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. |
| Q38101104 | Links between obesity, diabetes and ethnic disparities in breast cancer among Hispanic populations |
| Q37582430 | Lymph node involvement in immunohistochemistry-based molecular classifications of breast cancer |
| Q36863787 | Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program |
| Q35184055 | Modern reproductive patterns associated with estrogen receptor positive but not negative breast cancer susceptibility |
| Q33957073 | Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies |
| Q35684581 | Molecular basis of triple negative breast cancer and implications for therapy |
| Q39026644 | Obesity and Breast Cancer |
| Q38649483 | Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. |
| Q30361298 | Obesity and cancer pathogenesis. |
| Q37947906 | Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin |
| Q35687528 | Obesity and male breast cancer: provocative parallels? |
| Q38062392 | Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis |
| Q37690552 | Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression |
| Q61799036 | Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms |
| Q35634515 | Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium |
| Q37316516 | Obesity, mortality, and life years lost associated with breast cancer in nonsmoking US Women, National Health Interview Survey, 1997-2000. |
| Q64082531 | Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells |
| Q36245578 | Occurrence of breast cancer subtypes in adolescent and young adult women |
| Q64063651 | Perceived risk of colorectal and breast cancers among women who are overweight or with obesity |
| Q40393917 | Physical activity and breast cancer risk by pathological subtype |
| Q27687674 | Physical activity and cancer |
| Q46601825 | Physical activity and risk of breast cancer overall and by hormone receptor status: the European prospective investigation into cancer and nutrition |
| Q37717233 | Physical activity and the risk of postmenopausal breast cancer - the Norwegian Women and Cancer Study |
| Q90073087 | Progesterone and Breast Cancer |
| Q37018109 | Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study |
| Q35928943 | Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status |
| Q33619700 | Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study |
| Q36567726 | Relation between self-recalled childhood physical activity and adult physical activity: The women's health initiative |
| Q36542202 | Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. |
| Q26774591 | Risk factors and biomarkers of life-threatening cancers |
| Q28392744 | Self-recalled Youth Physical Activity and Postmenopausal Cardiovascular Disease |
| Q35130819 | Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 |
| Q36114823 | Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient Population |
| Q37974246 | Targeting the subtypes of breast cancer: rethinking investigational drugs |
| Q38295108 | The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer |
| Q90292637 | The Many Faces of Obesity and Its Influence on Breast Cancer Risk |
| Q26747486 | The Obesity-Breast Cancer Conundrum: An Analysis of the Issues |
| Q92241366 | The association between DXA-derived body fat measures and breast cancer risk among postmenopausal women in the Women's Health Initiative |
| Q27021293 | The impact of overweight and obesity on breast cancer: data from Switzerland, so far a country little affected by the current global obesity epidemic |
| Q36579794 | The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer |
| Q35186166 | The relationship of psychosocial factors to mammograms, physical activity, and fruit and vegetable consumption among sisters of breast cancer patients |
| Q38314472 | The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers |
| Q37692345 | Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity. |
| Q37525906 | Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications |
| Q35117423 | Tumor mechanics and metabolic dysfunction |
| Q46124505 | Web-based self-monitoring for weight loss among overweight/obese women at increased risk for breast cancer: the HELP pilot study |
Search more.